PCOS Treatment: What Actually Helps — From Lifestyle and the Pill to Metformin, Anti-Androgens, and Fertility Options

Short Answer

PCOS does not have a one-and-done cure, and there is no single treatment that works for everyone. That can sound discouraging, but it also means care should be built around your priority: irregular or absent periods, excess-androgen symptoms like unwanted hair, acne, or scalp thinning, insulin resistance and metabolic risk, weight-related concerns, mood, or trying to get pregnant. The FDA describes PCOS care as individualized and symptom-based, and NICHD notes that many commonly used treatments are not approved specifically to treat PCOS itself — they are used to manage symptoms and related risks. Lifestyle support is usually the base layer, not because PCOS is "your fault," but because sleep, movement, food patterns, stress load, and weight changes can all push on insulin, inflammation, and hormones over time. As one recent PCOS pathways review puts it, "Current therapeutic strategies often combine lifestyle modifications with pharmacological interventions to address the multifaceted symptoms of PCOS." (Front. Endocrinol. 2025, DOI 10.3389/fendo.2025.1722649; FDA Office of Women's Health)

From there, the plan depends on the goal. If you are not trying to get pregnant, combined hormonal birth control is commonly used to make bleeding more predictable and reduce androgen-driven symptoms such as acne and hirsutism. If insulin resistance or metabolic risk is a major part of the picture, a clinician may consider insulin-sensitizing treatment, most often metformin; myo-inositol is a supplement some people ask about, but the 2023 international guideline describes its clinical benefits as more limited than metformin's, so it belongs in a clinician-guided conversation rather than a "must-take" bucket. If hair or skin symptoms remain the main problem, anti-androgen medication such as spironolactone may be considered, typically with attention to pregnancy prevention because this class is not used casually when pregnancy is possible. If the goal is pregnancy, care shifts away from cycle-suppression medicines and toward ovulation induction: the 2023 International Evidence-Based PCOS Guideline names letrozole as first-line pharmacologic treatment for ovulation induction in infertile anovulatory women with PCOS when there are no other infertility factors; clomiphene, metformin combinations, gonadotropins, IVF, or other fertility options may fit different situations. Which class fits you, whether classes are combined, and what dose is safe are medical decisions — this page explains what each option is for, never how to prescribe it. (2023 International PCOS Guideline (PMC10505534))

Welltory does not diagnose PCOS, treat PCOS, or tell you which medicine to take. What it can do is help you watch the terrain while you and your clinician work the plan: how your cycle timing, sleep, heart rate variability, resting heart rate, and recovery patterns shift over months. That kind of feedback can make the body's response feel less invisible. It is context for a medical conversation — not a diagnosis, not proof that a medication is working, and not a reason to start, stop, or change treatment on your own.

PCOS treatment at a glance — matched to your goal

PCOS treatment is not a single ladder everyone climbs. It is a goal-based plan: what matters most right now, what your body is doing, what your risks look like, and whether pregnancy is part of the near-term picture. The same person may need cycle protection in one season, metabolic support in another, and ovulation-focused care later. That is why none of the choices below should be made from a checklist alone. The 2023 International Evidence-Based PCOS Guideline frames care as individualized, evidence-based, and shared between the person with PCOS and their clinician; it also emphasizes lifestyle, emotional wellbeing, medical therapy when indicated, and safer fertility management. (2023 International PCOS Guideline, Hum. Reprod. (PubMed 37580037))

This table is coverage-level and intentionally uses no doses. The class-to-purpose pairings above are aligned with the 2023 International Evidence-Based PCOS Guideline: combined oral contraceptive pills are described as first-line pharmacological treatment for menstrual irregularity and hyperandrogenism; metformin is recommended primarily for metabolic features; inositol has limited clinical benefits; anti-androgens can be considered with effective contraception for hirsutism; and letrozole is recommended as first-line pharmacological ovulation induction for infertile anovulatory women with PCOS when there are no other infertility factors. (2023 International PCOS Guideline (PMC10505534))

The big picture: no cure, but very manageable — and treatment follows your goal

There is no cure for PCOS. That can feel heavy, but it also matters because it keeps the goal honest: treatment is not about "fixing" your body once and for all. It is about managing the parts of PCOS that are active for you now — irregular ovulation, long gaps without bleeding, androgen symptoms, insulin resistance, fertility, sleep, mood, or long-term metabolic risk. NIH MedlinePlus puts the practical message plainly: PCOS has no current cure, but symptoms can be managed; NICHD describes treatment as varying by specific symptoms and related health problems. (NIH MedlinePlus Magazine)

There also is not a single medication that treats PCOS as a whole. The 2023 guideline notes that medical therapy is generally not approved for use specifically in PCOS and is recommended in a symptom-directed, evidence-based way — which is why a clinician may use one class for cycle regulation, another for metabolic features, and a different plan entirely when pregnancy is the goal. (2023 International PCOS Guideline (PMC10477934))

Because PCOS shows up so differently from person to person, the single most useful question is: what are we treating first? Regulating cycles, calming androgen symptoms, improving insulin resistance, and helping with fertility can call for different tools. A patient-centered scoping review frames it plainly: "PCOS management during perimenopause and menopause requires a holistic, person-centered approach integrating lifestyle and complementary strategies" to address physical, hormonal, and mental-health challenges — a principle that holds across the lifespan, not only later. (Lifestyle & Complementary Approaches to PCOS scoping review (PMC12999536))

A word on framing before the specifics: being told to "just lose weight" is one of the most common and demoralizing experiences people with PCOS describe. Weight support can matter for some goals, but it is not the whole story, and it is not a moral test. The 2023 guideline explicitly emphasizes healthy lifestyle, prevention of excess weight gain, shared decision-making, and awareness of weight stigma — not shame-based care. (2023 International PCOS Guideline (PubMed 37580037))

Lifestyle — the foundation under everything

Lifestyle is the base layer because PCOS is not only an ovarian condition. It is also metabolic, cardiovascular, inflammatory, psychological, and sleep-related for many people. NICHD describes PCOS symptoms and related health issues as spanning menstrual irregularities, acne, insulin resistance, cardiovascular issues, and obstructive sleep apnea; the 2023 guideline says assessment and management should address reproductive, metabolic, cardiovascular, dermatologic, sleep, and psychological features. (NICHD: PCOS)

In the body, the reason lifestyle matters is insulin signaling. When insulin resistance is present, the pancreas has to push out more insulin to move glucose into cells. Higher insulin can amplify ovarian androgen production in susceptible people, and those androgens can show up as acne, hirsutism, scalp hair thinning, irregular ovulation, or long cycles. This can happen across body sizes. In a study separating hyperandrogenic from non-hyperandrogenic PCOS, "we confirm that insulin resistance drives the hyperandrogenic phenotype independently of obesity" — which is why insulin-focused care is not just "weight advice." (Divergent pathophysiological drivers of PCOS (PMC12913134))

The most-studied lifestyle pieces are the unglamorous ones: nutrition, physical activity, sleep, stress management, and behavioral support that you can actually repeat. In a scoping review of non-drug PCOS care, "Diet and physical activity were the most commonly investigated interventions," and a Canadian care review lists "personalized lifestyle modifications and education" among the top opportunities to improve PCOS care. (Lifestyle & Complementary Approaches scoping review (PMC12999536); Opportunities to improve PCOS care in Canada (PMC13078828))

Two caveats keep this from becoming another "try harder" lecture. First, lifestyle is a foundation, not a guaranteed fix. Many people also need medication for cycles, skin, metabolic risk, or fertility, and needing medication is not failure. Second, the 2023 guideline does not crown one perfect PCOS diet or exercise pattern; it emphasizes sustainable healthy lifestyle, prevention of excess weight gain, and individualized support, while minimizing weight bias and stigma. (2023 International PCOS Guideline (PMC10505534))

Combined hormonal birth control — the common first medication for cycles and androgens

When the priority is regulating irregular periods and easing androgen symptoms — unwanted hair or acne — and pregnancy is not the current goal, a clinician often considers combined hormonal contraception, meaning estrogen-plus-progestin pills or related methods such as the patch or ring. The 2023 PCOS guideline describes combined oral contraceptive pills as first-line pharmacological treatment for menstrual irregularity and hyperandrogenism, with no single preferred preparation for everyone. (2023 International PCOS Guideline (PMC10505534))

The "why" is hormonal patterning. In PCOS, ovulation may be irregular, so progesterone exposure can be irregular too. Long gaps without ovulation can leave the uterine lining under prolonged estrogen stimulation. Hormonal contraception can create more predictable bleeding, reduce ovarian androgen production signals, raise sex hormone–binding globulin, and lower free androgen activity over time. That is why it can help with cycle predictability, acne, and hirsutism while also offering endometrial protection during long gaps without periods. (Progestogens for irregular uterine bleeding associated with anovulation (PMC7061495))

⚠️ Clinician-directed only — no self-dosing. Specific pills, formulations, and doses are deliberately omitted. Which method is appropriate, and whether an estrogen-containing method is safe for you, is a medical decision. CDC guidance for combined hormonal contraceptives requires medical eligibility screening and blood-pressure assessment, and it flags situations where risk may be unacceptable or usually outweigh benefit, including certain blood-pressure ranges, thrombophilia, thromboembolic history, migraine with aura, smoking-related cardiovascular risk, and multiple cardiovascular risk factors. Do not choose, start, stop, or switch hormonal treatment on your own. (CDC: Combined Hormonal Contraceptives — Medical Eligibility)

Insulin-sensitizers — metformin and myo-inositol

Much of PCOS care comes back to insulin resistance. When insulin signaling is strained, your body may compensate with higher insulin levels; in PCOS, that can feed androgen production and make cycles, skin, and metabolic markers harder to stabilize. This is why insulin-targeting approaches exist alongside lifestyle support rather than instead of it.

Metformin is a medication originally used for diabetes. In PCOS, the 2023 guideline places it mainly in the metabolic lane: it can be considered for metabolic features such as insulin resistance, glucose, lipid, and anthropometric outcomes, especially when metabolic risk is part of the picture. The guideline also notes that metformin may be considered for irregular cycles when combined oral contraceptives are contraindicated, not accepted, or not tolerated — but that does not make it a hormone reset or a stand-alone cure. (2023 International PCOS Guideline (PMC10477934))

A 2026 meta-analysis of 51 randomized trials found that "metformin does not significantly affect circulating gonadotropin levels in reproductive-age women with PCOS," a useful reminder: metformin works primarily through metabolic pathways, not by simply "normalizing all hormones." (Effect of Metformin on Gonadotropin Levels in PCOS, Diabetes Obes. Metab. 2026, DOI 10.1111/dom.70719)

Myo-inositol is a supplement, not a drug. Mechanistically, a 2026 review describes how "myo-inositol restores insulin signaling via inositolphosphoglycan second-messenger pathways, thereby attenuating hyperinsulinemia-driven androgen excess" — a plausible insulin-focused rationale. But plausibility is not the same as dependable clinical benefit. A systematic review and meta-analysis used to inform the 2023 guideline concluded that evidence for inositol in PCOS is limited and inconclusive; the 2023 guideline says inositol may be considered based on individual preferences and values, with limited harm but limited clinical benefits for outcomes such as ovulation, hirsutism, or weight. (Redox-endocrine triad in PCOS review (DOI 10.3389/fendo.2026.1825853); Inositol for PCOS systematic review (PubMed 38163998))

⚠️ Clinician-directed only. Whether metformin fits you, and at what dose, is a prescribing decision; metformin has its own side-effect profile and cautions. Myo-inositol should be discussed with your clinician or pharmacist like any other product — name, brand, ingredients, and amount — because supplement quality and combinations vary. Neither metformin nor inositol is a cure for PCOS. (Inositol for PCOS systematic review (PubMed 38163998))

Anti-androgens — for hair and skin symptoms

When the main concern is hirsutism, acne, or scalp hair thinning driven by androgen activity, a clinician may add an anti-androgen medication such as spironolactone. These medicines reduce androgen effects at the skin and hair follicle level, so they are used for symptoms that can be deeply visible and emotionally loaded. PCOS's androgen-driven symptoms are among its defining features — one qualitative study notes simply that "PCOS causes infertility, irregular periods and hirsutism." (Trans and Nonbinary Peoples' Experiences of PCOS (PMC13101570))

In the 2023 guideline, anti-androgens are not the first thing everyone starts. They can be considered with effective contraception for hirsutism when response to combined oral contraceptive pills and/or cosmetic therapy is not enough. Laser and other cosmetic approaches may also be part of care, because hair symptoms are both biological and practical: you may need the hormone signal addressed and a way to manage what is already growing. (2023 International PCOS Guideline (PMC10477934))

⚠️ Clinician-directed only. Spironolactone and other anti-androgens require medical supervision and reliable contraception during use because of possible harm to a developing pregnancy. Suitability, monitoring, and dose are clinician decisions; do not self-source or stack anti-androgens with supplements or other hormone-active products without medical review. (Anti-androgens in PCOS: systematic review & meta-analysis (PubMed 37583655))

Fertility — when the goal is getting pregnant

If you are trying to conceive, the treatment goal changes completely. Hormonal contraception is set aside, and the focus becomes restoring ovulation. PCOS-related fertility problems are often linked to anovulation — not releasing an egg regularly — and NICHD recommends working with a healthcare provider to rule out other causes before treating infertility as PCOS-related. (NICHD: Treatments for Infertility Resulting from PCOS)

The usual first medication step is ovulation induction. In the 2023 International Evidence-Based PCOS Guideline, letrozole is recommended as first-line pharmacological treatment for ovulation induction in infertile anovulatory women with PCOS when there are no other infertility factors. Clomiphene is another ovulation-inducing option, and metformin can be used in selected fertility scenarios, but people should be told when more effective ovulation agents exist. If oral medicines do not work, care can step up to specialist treatments such as gonadotropins, ovarian surgery in selected cases, or assisted reproductive technology. (2023 International PCOS Guideline (PMC10505534))

NICHD also summarizes why letrozole is used in this setting: it briefly slows estrogen production, which leads the body to make more follicle-stimulating hormone — a signal needed for ovulation — and an NICHD-supported study found letrozole more effective than clomiphene for ovulation and live birth in women with PCOS. (NICHD: Treatments for Infertility Resulting from PCOS)

⚠️ Clinician-supervised only. Ovulation-induction medicines, their sequence, and their doses are decisions for a fertility clinician. They require timing, pregnancy exclusion when relevant, monitoring, and counseling about risks such as multiple pregnancy or ovarian response. Do not self-source or self-dose fertility medication. (2023 International PCOS Guideline (PMC10505534))

Mood, anxiety, and sleep — treat them as part of the plan

PCOS is not only reproductive and metabolic. Anxiety, low mood, sleep problems, body-image distress, and quality-of-life burden are part of the condition for many people, not a personal weakness. The 2023 guideline says depression and anxiety symptoms are significantly increased in PCOS and should be screened for in all women with PCOS, with psychological assessment and therapy when indicated; it also recommends considering sleep features, including screening for obstructive sleep apnea when symptoms suggest it. (2023 International PCOS Guideline (PMC10505534))

That fits what newer research keeps showing: "Patients with polycystic ovary syndrome (PCOS) often experience anxiety, depression, and sleep problems in addition to endocrine and metabolic abnormalities, which may adversely affect their quality of life and disease progression." These symptoms deserve to be part of the treatment conversation, not treated as "stress" you should simply push through. (Network structure of anxiety, depression, and sleep symptoms in PCOS (DOI 10.3389/fpsyt.2026.1738355))

There is encouraging evidence that non-drug approaches can help the mental-health side. In a network meta-analysis of 25 randomized trials in PCOS, "Effective interventions included emotion-focused therapy (EFT), peer support (PS), omega-3 plus vitamin E (O3+VE), and mindfulness stress management (MSM)" for anxiety and depression symptoms — while the same analysis found some other options showed no significant benefit versus control. The practical takeaway is not that one therapy name is magic. It is that the psychological load of PCOS is real, measurable, and addressable, and therapy or structured support belongs alongside medical care. (Network meta-analysis of interventions for anxiety and depression in PCOS (PMC12883158))

⚠️ If low mood turns into thoughts of not wanting to be here, or of harming yourself, treat that as urgent — reach out to a clinician now, and in a crisis in the US call or text 988, or use 988 chat, any time. This is a general safety note; it is not specific to PCOS. SAMHSA describes 988 as 24/7 support by call, text, or chat for mental-health, substance-use, or suicidal crisis. (SAMHSA: 988 Suicide & Crisis Lifeline)

Putting it together — and knowing when to escalate

Because PCOS varies so much, the "right" treatment is really the right combination, revisited over time. Mild concerns may improve with lifestyle and tracking. Cycle or skin symptoms may need hormonal or anti-androgen treatment. Metabolic risk may point toward metformin and more structured cardiometabolic follow-up. When the goal becomes pregnancy, the plan pivots to ovulation induction. If first-line care is not working — cycles still absent, hirsutism not improving, acne flaring, labs worsening, or conception not happening — that is a reason to return to your clinician or ask for referral to a gynecologist, endocrinologist, dermatologist, or fertility specialist. It is not a reason to give up or self-experiment. (NICHD: PCOS)

⚠️ Red flag — don't wait: very infrequent periods or long stretches with no bleeding can, over time, raise concern about the uterine lining, because irregular ovulation may mean prolonged estrogen exposure without regular progesterone withdrawal. The 2023 guideline says increased premenopausal endometrial-cancer risk should be recognized while absolute risks remain low; reviews of PCOS guidelines also note evaluation when abnormal bleeding, spotting, or prolonged amenorrhea is present. Any unusually heavy, prolonged, or between-period bleeding should be assessed. CDC advises talking with a healthcare provider if bleeding lasts longer than 7 days or is heavy enough that you need to change a pad or tampon nearly every hour. This is a "get it checked" flag, not a reason to panic. (2023 International PCOS Guideline (PMC10505534); CDC: Common Reproductive Health Concerns for Women)

What Welltory adds: feedback on your tactics, not treatment

Welltory does not treat PCOS, diagnose PCOS, or tell you which medication to take. No app should. What it can do is close the feedback loop around the tactics you and your clinician choose. PCOS treatment is judged over months, not days. The useful question is rarely "did I have one good day?" It is "over the next few cycles, are my cycle timing, sleep, recovery, stress load, and symptoms moving in a better direction?"

Welltory tracks cycle patterns alongside your body's stress-and-recovery signals — heart rate variability (HRV), resting heart rate, sleep, and recovery — so you are not relying only on memory. After starting a pill, metformin, an inositol trial, an exercise routine, therapy, or a fertility plan, you can bring a dated record of how your body responded. That turns "I think it's helping" into a pattern your clinician can discuss with you.

Differentiator: NICHD, Johns Hopkins, Mayo, Cleveland Clinic, and NHS all explain the treatments and say "work with your doctor" and "make lifestyle changes" — but none give you the instrument to see whether your chosen tactics are actually working across the months that PCOS treatment plays out over, and none pair that with a physiological signal like HRV, resting heart rate, sleep, and recovery. That feedback-on-tactics loop is Welltory's gap to own — as context for the conversation, never as treatment or a diagnostic claim.

How we made it

Made with AI tools, then edited, fact-checked, and medically reviewed by the Welltory team. Every medical claim was checked against authoritative PCOS sources, including the 2023 International Evidence-Based PCOS Guideline, NIH/NICHD information on PCOS and PCOS-related infertility, CDC contraceptive eligibility guidance, and Mayo Clinic patient guidance on PCOS diagnosis and treatment.

Before publication, the piece was medically reviewed to make sure it does not diagnose you, prescribe treatment, give medication doses, or frame weight and fertility as personal failures. PCOS care depends on your symptoms, goals, lab results, cycle history, metabolic health, and pregnancy plans, so treatment decisions belong with your clinician.

Discounts for blog readers: up to 36% off

See what affects your energy, stress, sleep, and daily state with Welltory

Explore your data